The objective of the drug supply chain surveillance system is to facilitate a coordinated approach and infrastructure to support data collection and analysis activities. Continued collaboration…

Ended Awarded Last action

Contract number
75F40121F19004
Awardee
Awarding agency
Obligated
$23,871,502

Award facts

Opportunity
  • RFTOQ1237912 Solicitation number
Contract value 100% obligated
$23,871,502.15 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 -$344
Supplemental Agreement for work within scope P00006 $8,945,243
Other Administrative Action P00005 $364,980
Other Administrative Action P00004 $0
Exercise an Option P00003 $8,237,065
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $6,324,558

About this award

The U.S. Food and Drug Administration (FDA) awarded a contract to Deloitte & Touche LLP, a major professional services firm, to provide a Drug Supply Chain Surveillance System. The $23,871,502.15 contract is a Blanket Purchase Agreement (BPA) Call under the CDER Information Technology Support And Program Management Support Services BPA. The objective is to facilitate a coordinated approach and infrastructure to support data collection and analysis activities. No set-aside was used. The prime contractor, Deloitte & Touche LLP, has subcontracted a portion of the work to Apptad Inc., a self-certified small disadvantaged business, to provide data management and analytics services in support of this FDA initiative.

Description

The objective of the drug supply chain surveillance system is to facilitate a coordinated approach and infrastructure to support data collection and analysis activities. Continued collaboration between FDA and the industry has provided opportunities

Quick answers

Who was awarded contract 75F40121F19004?

75F40121F19004 was awarded to Deloitte & Touche LLP by Food and Drug Administration (Department of Health and Human Services) on April 14, 2021.

How much is contract 75F40121F19004 worth?

The government has obligated $23,871,502 on 75F40121F19004.

Is contract 75F40121F19004 an order under another contract?

Yes. 75F40121F19004 is a BPA call under HHSF223201700001B, a blanket purchase agreement, on CDER Information Technology Support And Program Management Support Services BPA.

Was contract 75F40121F19004 competed?

The extent of competition for 75F40121F19004 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award